Syndax Pharmaceuticals (SNDX) Earnings Date & Reports

Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

SNDX is expected to report earnings to rise 12.82% to -93 cents per share on November 11

Syndax Pharmaceuticals SNDX Stock Earnings Reports

Q3'25

Est.

$-0.94

Q2'25

Beat

by $0.18

Q1'25

Beat

by $0.26

Q4'24

Missed

by $0.26

Q3'24

Beat

by $0.09

The last earnings report on August 04 showed earnings per share of -82 cents, beating the estimate of -100 cents. With 2.97M shares outstanding, the current market capitalization sits at 1.08B.

View a ticker or compare two or three

Compare

SNDX